GSK Investigational Site

Oberpullendorf 7350

0 studies enrolling now · 3 studies all time

What they study most

Crohn's Disease

Studies at this site

• An Active Treatment Study to Induce Clinical Response and/or Remission With GSK1605786A in Subjects With Crohn's Disease — Stopped early
• Open-Label Extension Study of GSK1605786A — Stopped early
• GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease — Stopped early